Prescription drug · ANDA
Dichlorphenamide NDC 16571-242
Dichlorphenamide 50 mg/1 · Tablet · Oral · Rising Pharma Holdings, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 16571-242-01 | 16571024201 | 100 TABLET in 1 BOTTLE (16571-242-01)Marketed from Nov 18, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dichlorphenamide
- Generic name (nonproprietary)
- dichlorphenamide
- Active ingredients
- Dichlorphenamide — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Rising Pharma Holdings, Inc.NDC labeler code 16571
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218783
- Marketing start
- Listing expires
- Other FDA classes
- Carbonic Anhydrase Inhibitors (Mechanism)Sulfonamides (Chemical structure)
- Identifiers
- Product ID 16571-242_3ef66eca-f35a-46a8-bebe-b286dfbbb376SPL ID 3ef66eca-f35a-46a8-bebe-b286dfbbb376SPL set ID 35b9c81a-5062-451d-8b0c-1b599113aa6cRxCUI 197594UNII VVJ6673MHYUPC 0316571242016
- Pharmacologic class
- Carbonic Anhydrase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N416571024201followed by a unit qualifier and the quantityPackage 16571-0242-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Dichlorphenamide tablets are indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants. Dichlorphenamide tablets are an oral carbonic anhydrase inhibitor indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 16571-242
- What is NDC 16571-242?
- 16571-242 is the product NDC for Dichlorphenamide, Dichlorphenamide 50 mg/1 tablet, listed with the FDA by Rising Pharma Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Dichlorphenamide.
- What is the active ingredient?
- Dichlorphenamide.
- Who is the labeler?
- Rising Pharma Holdings, Inc., NDC labeler code 16571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Dichlorphenamide?
- 1 other product NDC are listed under this name. See all Dichlorphenamide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Dichlorphenamide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Dichlorphenamide | Dichlorphenamide 50 mg/1 | TabletOral | Torrent pharmaceuticals limited | 13668-676 | 13668-0676-0113668-0676-30 |